MetwareBio will participate in ESC Congress 2026 in Munich, Germany, from August 28-31, 2026. Visit us at Booth F250, Hall B2, to discuss how metabolomics, proteomics, lipidomics, spatial metabolomics, and multi-omics analysis can support cardiovascular research questions, including metabolic remodeling, lipid biology, inflammation-related pathways, biomarker discovery research, and mechanism-oriented studies.
| Event Information | Details |
|---|---|
| Event | ESC Congress 2026 |
| Date | August 28-31, 2026 |
| Location | Munich, Germany |
| Booth | F250, Hall B2 |
1. WHY CARDIOVASCULAR RESEARCH BENEFITS FROM MULTI-OMICS
Cardiovascular diseases involve interconnected changes across metabolism, lipid regulation, inflammation, immune activity, oxidative stress, and tissue remodeling. Understanding these interactions requires approaches that can connect molecular changes with biological mechanisms.
Multi-omics integrates complementary molecular layers to help researchers move from individual molecular changes toward pathway-level interpretation. Metabolomics can reveal metabolic pathway alterations, lipidomics can characterize lipid remodeling and signaling changes, proteomics can investigate pathway regulation, and spatial metabolomics can add tissue-level molecular context.
2. CARDIOVASCULAR RESEARCH QUESTIONS METWAREBIO CAN HELP ADDRESS
2.1 Cardiovascular Metabolism and Metabolic Remodeling
Metabolic dysfunction is closely linked to cardiovascular health. Metabolomics can support studies of glucose metabolism, fatty acid utilization, amino acid metabolism, mitochondrial function, and metabolic adaptation across disease models, interventions, and treatment conditions.
2.2 Lipid Biology and Cardiovascular Risk
Lipidomics provides a broader view of lipid species, lipid remodeling, and signaling pathways beyond traditional lipid measurements. It can support research into lipid-associated mechanisms, inflammatory lipid mediators, and cardiovascular phenotypes.
2.3 Inflammation and Immune-Metabolic Regulation
Inflammation, immune responses, oxidative stress, and metabolism interact during cardiovascular disease progression. Integrated proteomics and metabolomics can help investigate these connected biological processes.
2.4 Biomarker Discovery and Treatment Response Research
Multi-omics analysis can help prioritize research-use biomarker candidates by integrating evidence from metabolites, proteins, lipids, and biological pathways.
3. WHICH OMICS TECHNOLOGY FITS YOUR CARDIOVASCULAR RESEARCH QUESTION?
| Research Question | Recommended Approach | Research Value |
|---|---|---|
| How is metabolism altered? | Metabolomics | Identify metabolic pathway changes and biochemical signatures |
| How does lipid metabolism contribute? | Lipidomics + metabolomics | Investigate lipid remodeling and metabolic adaptation |
| Which pathways are involved? | Proteomics + multi-omics | Connect molecular regulation with biological pathways |
| How do tissues differ? | Spatial metabolomics | Explore regional metabolite and lipid distribution |
4. MEET METWAREBIO AT ESC CONGRESS 2026 BOOTH F250
ESC Congress 2026 brings together cardiovascular researchers and healthcare professionals from around the world. At Booth F250, Hall B2, the MetwareBio team will discuss how omics strategies can support cardiovascular research goals.
Bring your research questions, study plans, sample types, or early-stage project ideas. We can discuss experimental design, omics technology selection, pathway interpretation, and strategies for integrating molecular datasets.
4.1 Why is multi-omics useful in cardiovascular research?
Multi-omics helps researchers integrate changes across metabolites, proteins, lipids, and other molecular layers to better understand cardiovascular mechanisms.
4.2 What can researchers discuss with MetwareBio at ESC Congress 2026?
Researchers can discuss study design, sample types, metabolomics, proteomics, lipidomics, spatial metabolomics, and multi-omics strategies.
4.3 How can metabolomics support cardiovascular research?
Metabolomics can help investigate metabolic pathway changes, energy metabolism, amino acid metabolism, oxidative stress, and other biochemical processes.
4.4 How can lipidomics contribute to cardiovascular studies?
Lipidomics can reveal lipid species and pathway changes associated with membrane biology, signaling, inflammation, and metabolic regulation.
Read More: Related Articles
Explore these curated articles to deepen your understanding of multi-omics strategies, proteomics technologies, and integrated approaches for biomedical research.
See how integrating proteomics, metabolomics, and lipidomics provides a systems-level view of metabolic diseases, connecting molecular changes to disease mechanisms.
Learn the strategic framework for combining proteomics and metabolomics data, from experimental design to biological interpretation for cardiovascular and metabolic research.
Start with the fundamentals of lipidomics, including lipid classification, analytical approaches, and how lipid profiling contributes to cardiovascular risk research.
Explore the advantages of multi-omics approaches across disease research, from identifying molecular signatures to building integrated biological models.
Understand how association analysis connects proteomics and metabolomics datasets to reveal coordinated molecular changes and pathway-level interactions.
Get answers to common questions about multi-omics data analysis workflows, from data integration strategies to biological interpretation for cardiovascular studies.
